Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Multiple Sclerosis and Related Disorders, 2025

Proximity Extension Assay identifies new targets of grey matter pathology in multiple sclerosis

van der Stok H., Coenen L., Weil M. et al.

npj Precision Oncology, 2025

Circulating T-cell receptor repertoire for cancer early detection

Li Y., Nahas M., Stephens D. et al.

eBioMedicine, 2025

The influence of metformin treatment on the circulating proteome

Connolly B., McCreight L., Slieker R. et al.

Science Immunology, 2025

Interactions between placental Hofbauer cells and L. monocytogenes change throughout gestation

Yoshida N., Appios A., Li Q. et al.

Science Immunology, 2025

Tissue origin and virus specificity shape human CD8 + T cell cytotoxicity

Niessl J., Müller T., Constantz C. et al.

Cancer Letters, 2025

PAF signaling axis functions as biomarker or target for esophageal squamous cell carcinoma diagnosis or treatment

Zhu Y., Wang F., Zhu Y. et al.

Translational Stroke Research, 2025

FLT1 as a Protective Factor in Ischemic Stroke: Insights from Real-World Pharmacovigilance and Genetic Evidence

Chen H., Yang J., Li Z. et al.

Atherosclerosis, 2025

Different plasma biomarker patterns associated with coronary atherosclerosis in low- versus high-risk individuals – an observational cross-sectional study

Cederström S., Wang Y., Lundman P. et al.

British Journal of Dermatology, 2025

Mendelian randomization identifies OX40 as a potential mediator of the effects of cigarette smoking in palmoplantar pustulosis

Smail A., Dand N., Liu X. et al.

Arteriosclerosis, Thrombosis, and Vascular Biology, 2025

Circulating Protein Mediators Linking Genetically Predicted Smoking to Abdominal Aortic Aneurysm: A Genomic-Proteomic Analysis

Yuan S., Khodursky S., Geng J. et al.

Alimentary Pharmacology & Therapeutics, 2025

Diagnostics of Autoimmune Hepatitis Enabled by Non‐Invasive Clinical Proteomics

Jensen A., Ytting H., Nielsen A. et al.

American Journal of Respiratory and Critical Care Medicine, 2025

Endotypes of Pseudomonas aeruginosa Infection in Bronchiectasis Are Associated with Inhaled Antibiotic Response: Results from Two Randomized, Double-Blind, Placebo-controlled Phase III Trials (ORBIT 3 and ORBIT 4)

Hull R., Stobo J., Abo-Leyah H. et al.

Immunity, 2025

Systems analysis of clinical malaria reveals proteomic perturbation and innate-adaptive crosstalk linked to disease severity

Lautenbach M., Wyss K., Yman V. et al.

Nature Communications, 2025

Linear and non-linear proteome-wide association studies provide novel insight into venous thromboembolism

Kong Y., Tang W., Kang H. et al.

European Heart Journal - Digital Health, 2025

Identifying congestion phenotypes using unsupervised machine learning in acute heart failure

Rastogi T., Hutin O., ter Maaten J. et al.

Bone, 2025

Large-scale proteomics analysis identifies plasma protein biomarkers and potential therapeutic targets for rheumatoid arthritis: A prospective study in UK Biobank

Ruan X., Zheng L., Dai Y. et al.

Free Radical Biology and Medicine, 2025

Elevated uric acid and impaired triglyceride metabolism predict mortality in women after ischemic stroke

Quek A., Teng O., Park J. et al.

Hearing Research, 2025

Investigating the causal relationship between circulating inflammatory proteins and tinnitus: Insights from a Mendelian Randomization study

He S., Wei M., Meng D. et al.

Brain Communications, 2025

Inflammatory markers in the cerebrospinal fluid linked to mortality in tuberculous meningitis

Dian S., Koeken V., Ardiansyah E. et al.

Lung Cancer, 2025

Safety, efficacy, and analysis of biomarkers in patients with advanced non-small cell lung cancer treated with the anti-IL1RAP antibody nadunolimab (CAN04) in combination with platinum doublet

Paulus A., Zemaitis M., Cicenas S. et al.

4555 publications